Similar articles

• Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

  Janson ET, Sørbye H, Welin S, Federspiel B, Grønbaek H, Hellman P, Mathisen O, Mortensen J, Sundin A, Thiis-Evensen E, Välimäki MJ, Oberg K, Knigge U. Janson ET, et al. Acta Oncol. 2010 Aug;49(6):740-56. doi: 10.3109/0284186X.2010.492791. Acta Oncol. 2010. PMID: 20553100 Review.
• Neuroendocrine tumour management: a team approach.

  Banfield A, Green S, Ramage JK. Banfield A, et al. Hosp Med. 2005 Jan;66(1):37-42. doi: 10.12968/hmed.2005.66.1.17534. Hosp Med. 2005. PMID: 15686165 Review.
• Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.

  Oberg K, Jelic S; ESMO Guidelines Working Group. Oberg K, et al. Ann Oncol. 2009 May;20 Suppl 4:150-3. doi: 10.1093/annonc/mdp158. Ann Oncol. 2009. PMID: 19454440 Review. No abstract available.
• ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

  Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP, O'Toole D; Barcelona Consensus Conference participants. Falconi M, et al. Neuroendocrinology. 2012;95(2):120-34. doi: 10.1159/000335587. Epub 2012 Feb 15. Neuroendocrinology. 2012. PMID: 22261872 No abstract available.
• Management of pancreatic neuroendocrine tumors.

  Halperin DM, Kulke MH. Halperin DM, et al. Gastroenterol Clin North Am. 2012 Mar;41(1):119-31. doi: 10.1016/j.gtc.2011.12.003. Gastroenterol Clin North Am. 2012. PMID: 22341253 Review. No abstract available.